These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Combined therapy with 5-aminosalicylic tablets and enemas for maintaining remission in ulcerative colitis.
    Author: d'Albasio G, Trallori G, Gavazzi O, Bardazzi G, Vannozzi G, Frittelli G, Cini E, Falai T, Varini C, Morettini A.
    Journal: Ital J Gastroenterol; 1991 Jan; 23(1):12-4. PubMed ID: 1747494.
    Abstract:
    A combined therapy with 5-aminosalicylic (5-ASA) tablets (1.6gr/day) and 5-ASA enemas (4gr/twice weekly) was evaluated for maintaining remission of ulcerative colitis in 40 patients. All patients were in complete remission which had been maintained for at least 1 month. The remission was assessed by clinical, endoscopic and histological criteria. Clinical and endoscopical evaluations were performed at intervals of 2 and 6 months, respectively. The relapse-rate associated with this combined therapy was 7.5% at 6 months and 16% at 12 months. In comparison with previous investigations using continuous sulphasalazine, our study showed that the combination of 5-aminosalicylic tablets and enemas provided low relapse rates both at 6 and 12 months, suggesting a potential effectiveness in this form of treatment. Further studies are needed to confirm this result with controlled clinical trials.
    [Abstract] [Full Text] [Related] [New Search]